Medicare reform bill improves laboratory test reimbursement
This article was originally published in Clinica
Executive Summary
The Medicare regulatory relief bill, approved by the US House last week, contains a few noteworthy provisions for the medical device industry. Although the bipartisan Medicare Regulatory and Contracting Reform Act (MRCRA) of 2001 is primarily aimed at streamlining the regulatory process for Medicare providers, it also begins the process of creating an open and rational reimbursement system for clinical laboratory tests.